Intravenous nesiritide in acute heart failure

American Journal of Therapeutics

Volumn 12, Issue 3, 2005, Pages 233-237

  Knox, Mark A ^a,b   Dancy, Timothy ^a   Mook, William ^a   Pschirer, James J ^a  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Congestive; Health care charges; Heart failure; Natriuretic hormone

Indexed keywords

NESIRITIDE;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEALTH CARE COST; HEART EJECTION FRACTION; HOSPITAL ADMISSION; HOSPITAL CHARGE; HOSPITAL COST; HOSPITAL PHARMACY; HOSPITALIZATION; HUMAN; MALE; MEDICAL RECORD; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEALTH CARE COSTS; HEART FAILURE, CONGESTIVE; HOSPITAL BED CAPACITY, 300 TO 499; HOSPITALS, COMMUNITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; PATIENT READMISSION; RETROSPECTIVE STUDIES;

EID: 20444505702     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Graves E, Gillum B. 1994 summary: National Hospital Discharge Survey: advance data. Atlanta: National Center for Health Statistics 17, 1996.
2. Young JB, Abraham WT, Stevenson LW, et al. Intravenous nesiritide vs. nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. 2002;287:1531-1540.
3. Mills RM, Lejemtel TH, Horton DP, et al. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure. J Am Coll Cardiol. 1999;34:155-162.
4. Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med. 2000;343:246-253.